A Randomized, Controlled Trial of Oxycodone Versus Placebo in Patients With PostHerpetic Neuralgia and Painful Diabetic Neuropathy Treated With Pregabalin

Journal of Pain

Volumn 11, Issue 5, 2010, Pages 462-471

  Zin, Che S ^a   Nissen, Lisa M ^a   O'Callaghan, James P ^b   Duffull, Stephen B ^a,d   Smith, Maree T ^a,c   Moore, Brendan J ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b GREENSLOPES PRIVATE HOSPITAL   (Australia)

^c Ctr for Drug Design and Development   (Australia)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

oxycodone; painful diabetic neuropathy; postherpetic neuralgia; Pregabalin

Indexed keywords

OXYCODONE; PLACEBO; PREGABALIN;

ADULT; AGED; ARTICLE; ATAXIA; AUSTRALIA; CLINICAL TRIAL; CONSTIPATION; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; HALLUCINATION; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROPATHIC PAIN; NEUROPATHIC PAIN SCALE; PAIN ASSESSMENT; PARALLEL DESIGN; PERIPHERAL EDEMA; POSTHERPETIC NEURALGIA; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; SWEAT GLAND DISEASE; SWEATING; TREMOR; VISUAL ANALOG SCALE; VISUAL DISORDER; VOMITING;

AGED; AGED, 80 AND OVER; ANALGESICS; ANALGESICS, OPIOID; DIABETIC NEUROPATHIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; NEURALGIA; NEURALGIA, POSTHERPETIC; OXYCODONE; PAIN; PAIN MEASUREMENT; SLEEP; TIME FACTORS; TREATMENT OUTCOME;

EID: 77951652964     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2009.09.003     Document Type: Article

References (38)

1. Baron R. Mechanisms of disease: neuropathic pain - a clinical perspective. Nat Clin Pract Neurol 2 (2006) 95-106
2. Belliotti T.R., Capiris T., Ekhato I.V., Kinsora J.J., Field M.J., Heffner T.G., Meltzer L.T., Schwarz J.B., Taylor C.P., Thorpe A.J., Vartanian M.G., Wise L.D., Zhi-Su T., Weber M.L., and Wustrow D.J. Structure-activity relationships of pregabalin and analogues that target the alpha(2)-delta protein. J Med Chem 48 (2005) 2294-2307
3. Dworkin R.H., Backonja M., Rowbotham M.C., Allen R.R., Argoff C.R., Bennett G.J., Catherine Bushnell M., Farrar J.T., Galer B.S., Haythornthwaite J.A., Hewitt D.J., Loeser J.D., Max M.B., Saltarelli M., Schmader K.E., Stein C., Thompson D., Turk D.C., Wallace M.S., Watkins L.R., and Weisntein S.M. Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations. Arch Neurol 60 (2003) 1524-1534
4. Dworkin R.H., O'Connor A.B., Backonja M., Farrar J.T., Finnerup N.B., Jensen T.S., Kalso E.J., Loeser J.D., Miaskowski C., Nurmiko T.J., Portenoy R.K., Rice A.S.C., Stacey B.R., Treede R.D., Turk D.C., and Wallace M.S. Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain 132 (2007) 237-251
5. Farrar J.T., Young J.P., LaMoreaux L., Werth J.L., and Poole R.M. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94 (2001) 149-158
6. Fazen L.E., and Ringkamp M. The pathophysiology of neuropathic pain: A review of current research and hypotheses. Neurosurg Q 17 (2007) 245-262
7. Fink K., Dooley D.J., Meder W.P., Suman-Chauhan N., Duffy S., Clusmann H., and Gothert M. Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 42 (2002) 229-236
8. Galer B.S., and Jensen M.P. Development and preliminary validation of a pain measure specific to neuropathic pain: The Neuropathic Pain Scale. Neurology 48 (1997) 332-338
9. Gilron I., Bailey J.M., Tu D.S., Holden R.R., Weaver D.F., and Houlden R.L. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 352 (2005) 1324-1334
10. Gimbel J.S., Richards P., and Portenoy R.K. Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial. Neurology 60 (2003) 927-934
11. Grosskopf J., Mazzola J., Wan Y., and Hopwood M. A randomized, placebo-controlled study of oxcarbazepine in painful diabetic neuropathy. Acta Neurol Scand 114 (2006) 177-180
12. Hanna M., O'Brien C., and Wilson M.C. Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. Eur J Pain 12 (2008) 804-813
13. Hansson P.T., and Dickenson A.H. Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies. Pain 113 (2005) 251-254
14. Harden R.N. Chronic neuropathic pain - mechanisms, diagnosis, and treatment. Neurologist 11 (2005) 111-122
15. Jensen M.P., Dworkin R.H., Gammitoni A.R., Olaleye D.O., Oleka N., and Galer B.S. Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale. J Pain 6 (2005) 98-106
16. Lee T.M.C., Cheung C.C.Y., Chan J.K.P., and Chan C.C.H. Trail making across languages. J Clin Exp Neuropsychol 22 (2000) 772-778
17. Lesser H., Sharma U., LaMoreaux L., and Poole R.M. Pregabalin relieves symptoms of painful diabetic neuropathy: A randomized controlled trial. Neurology 63 (2004) 2104-2110
18. Low P.A., and Dotson R.M. Symptomatic treatment of painful neuropathy. JAMA 280 (1998) 1863-1864
19. Max M. Neuropathic pain syndromes. In: Max M., Portenoy R., and Laska E. (Eds). Advances in pain research and therapy, Vol 18 (1991), Raven Press Ltd, New York, NY 193-219
20. McNair D.M., Lorr M., and Droppleman L.F. Profile of mood states (POMS) manual (1992), Educational and Industrial Testing Service, San Diego, CA pp 1-28
21. Merskey H., and Bogduk N. Classification of Chronic Pain. 2nd ed. (1994), IASP Press, Seattle, WA p 394
22. Namaka M., Gramlich C.R., Ruhlen D., Melanson M., Sutton I., and Major J. A treatment algorithm for neuropathic pain. Clin Ther 26 (2004) 951-979
23. Ostelo R.W., and de Vet H.C. Clinically important outcomes in low back pain. Best Pract Res Clin Rheumatol 19 (2005) 593-607
24. Pappagallo M., and Haldey E.J. Pharmacological management of postherpetic neuralgia. CNS Drugs 17 (2003) 771-780
25. Reuben S.S., Connelly N.R., and Maciolek H. Postoperative analgesia with controlled-release oxycodone for outpatient anterior cruciate ligament surgery. Anesth Analg 88 (1999) 1286-1291
26. Rice A.S., and Maton S. Gabapentin in postherpetic neuralgia: A randomised, double blind, placebo controlled study. Pain 94 (2001) 215-224
27. Richter R.W., Portenoy R., Sharma U., Lamoreaux L., Bockbrader H., and Knapp L.E. Relief of painful diabetic peripheral neuropathy with pregabalin: A randomized, placebo-controlled trial. J Pain 6 (2005) 253-260
28. Rosenstock J., Michael T.B., LaMoreaux L., and Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: A double-blind, placebo-controlled trial. Pain 110 (2004) 628-638
29. Rowbotham M., Harden N., Stacey B., Berstein P., and Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. JAMA 280 (1998) 1837-1842
30. Salaffi F., Stancati A., Silvestri C.A., Ciapetti A., and Grassi W. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain 8 (2004) 283-291
31. Schmader K.E. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain 18 (2002) 350-354
32. Spreen O., and Strauss E. A compendium of neuropsychological tests. 2nd ed. (1998), Oxford University Press, New York, NY pp 533-547
33. Sunshine A., Olson N.Z., Colon A., Rivera J., Kaiko R.F., Fitzmartin R.D., Reder R.F., and Goldenheim P.D. Analgesic efficacy of controlled-release oxycodone in postoperative pain. J Clin Pharmacol 36 (1996) 595-603
34. Ware J.E., and Sherbourne C.D. The Mos 36-Item Short-Form Health Survey (Sf-36) .1. Conceptual-framework and Item selection. Med Care 30 (1992) 473-483
35. Watson C.P.N., and Babul N. Efficacy of oxycodone in neuropathic pain - a randomized trial in postherpetic neuralgia. Neurology 50 (1998) 1837-1841
36. Watson C.P.N., Moulin D., Watt-Watson J., Gordon A., and Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: A randomized controlled trial in painful diabetic neuropathy. Pain 105 (2003) 71-78
37. Woolf C.J., and Decosterd I. Implications of recent advances in the understanding of pain pathophysiology for the assessment of pain in patients. Pain 6 (1999) S141-S147
38. Zin C.S., Nissen L.M., Smith M.T., O'Callaghan J.P., and Moore B.J. An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy. CNS Drugs 22 (2008) 417-442